Change in Treatment Administration May Reduce Osteonecrosis in Pediatric ALL
The method of treatment administration in the JACLS ALL-97 and ALL-02 trials may have contributed to a lower incidence of osteonecrosis in Japanese children with acute lymphoblastic leukemia.
Source: OncLive